Rancho Cordova, California (PRWEB) November 27, 2013
With the continued escalation of drug development costs, BioPharma organizations are increasingly considering cloud computing applications as a means to improve operational efficiencies and to accelerate time to market. In the highly regulated drug development market, health science cloud applications must comply with and be validated against a growing list of global government requirements. US and EU requirements such as FDA 21 CFR Part 11, HIPAA, European Commission Privacy Directives and US FDA electronic signing regulations make it costly, time consuming and difficult for organizations to deploy internally developed applications that adhere to regulatory requirements. To address compliance needs and to accelerate time to value, SureClinical launched SureClinical Certified Cloud™ to give its life science and healthcare customers immediate access to the operational efficiencies and return on investment offered with its SureTrial suite of clinical trial applications.
SureClinical's SureTrial eTMF cloud solution is a suite of cloud-based applications delivered on the SureClinical Certified Cloud, purpose-built for clinical trials and validated against US and EU regulatory requirements. SureClinical has Certified Cloud data center operations in regional centers throughout North America and in Europe. The European Certified Cloud data centers meet the privacy standards of the European Commission's Directive on Data Protection.
"We are very excited to meet our customers’ demands for a highly secure, compliant and validated suite of cloud solutions purpose-built for health sciences. SureClinical’s Certified Cloud with its FDA-compliant SureTrial eTMF cloud application suite will enable BioPharma firms to confidently move mission-critical clinical tri
Copyright©2012 Vocus, Inc.
All rights reserved